(226 days)
The CONMED Mixing and Delivery Kit is intended for delivery of allograft, or synthetic bone graft materials to all orthopedic surgical sites. In addition, it is designed to facilitate pre-mixing of allograft or synthetic bone graft materials with IV fluids, blood, plasma, platelet rich plasma, bone marrow or other specific blood component(s) as deemed necessary by the clinical use requirements.
The CONMED Mixing and Delivery Kit consists of a piston syringe, curved luer camula, straight luer lock, obturator, and finnel. The kit is supplied a single use, disposable
The provided document is a 510(k) summary for the CONMED Mixing and Delivery Kit, seeking premarket notification clearance from the FDA. This type of document focuses on demonstrating substantial equivalence to a predicate device rather than providing a detailed study that proves a device meets specific acceptance criteria based on novel performance metrics. It's an application for regulatory clearance, not a peer-reviewed research paper.
Therefore, many of the requested details regarding acceptance criteria, study design, sample sizes, expert qualifications, and specific performance metrics are not present in this document. The document focuses on comparing the proposed device to a predicate device (Arthrex Mixing and Delivery System) based on design, materials, intended use, principles of operation, and technical characteristics.
Here's an analysis based on the information available:
1. Table of Acceptance Criteria and Reported Device Performance:
The document doesn't provide a table of numerical acceptance criteria with corresponding reported device performance. Instead, it generally states that testing was completed to demonstrate the device "performs as intended and is substantially equivalent to the predicate device."
| Acceptance Criteria (Implied by Substantial Equivalence) | Reported Device Performance (Implied by Testing) |
|---|---|
| Intended Use: For delivery of allograft, autograft, or synthetic bone graft materials to all orthopedic surgical sites. Additionally, designed to facilitate pre-mixing of these materials with IV fluids, blood, plasma, platelet rich plasma, bone marrow or other specific blood component(s). | Meets the stated intended use. (Implied by comparison to predicate) |
| Technological Characteristics: For mixing and delivery of allograft, autograft, and synthetic bone graft materials to all orthopedic sites. | Meets the stated technological characteristics. (Implied by comparison to predicate and testing) |
| Materials: Commonly used materials in the medical device industry. | Uses commonly used materials. (Implied by comparison) |
| Reliability: Device maintains functionality over time. | Testing completed to demonstrate reliability. |
| Biocompatibility: Materials are safe for biological contact. | Testing completed to demonstrate biocompatibility. |
| Sterilization: Device can be effectively sterilized. | Testing completed to demonstrate sterilization efficacy. |
| Shelf-life: Device maintains integrity and functionality for a specified period (18 months for proposed, 5 years for predicate). | Testing completed to demonstrate shelf-life. (Note: Proposed device has 18-month shelf-life, predicate has 5-year. This difference is listed but not presented as a failure of an acceptance criterion for the proposed device, as it's a characteristic, not necessarily a failure if cleared). |
| Simulated Use Testing: Device performs as expected in simulated clinical scenarios. | Testing completed for simulated use. |
2. Sample Sizes Used for the Test Set and Data Provenance:
- Sample Size for Test Set: Not specified. The document mentions "testing has been completed" but does not detail the number of devices or trials used for any of the performance tests (Reliability, Biocompatibility, Sterilization, Shelf-life, Simulated Use Testing).
- Data Provenance: Not specified. The document does not mention the country of origin of the data, nor whether the studies were retrospective or prospective.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications:
- Not Applicable. This document describes a medical device seeking 510(k) clearance, not an AI/ML algorithm requiring expert-established ground truth for a diagnostic task. The "ground truth" for this type of device relates to its physical performance, material properties, and intended function, which are assessed through engineering and biological testing, not expert consensus on interpretations.
4. Adjudication Method for the Test Set:
- Not Applicable. As above, adjudication methods like 2+1 or 3+1 are relevant for interpreting diagnostic data, not for assessing the physical performance and safety of a mixing and delivery kit.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done:
- No. This type of study is typically done for diagnostic tools or AI algorithms that assist human interpretation. This document is for a physical medical device (mixing and delivery kit), and therefore an MRMC study is not relevant or included.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done:
- Not Applicable. This is not an algorithm or AI device. It is a physical medical device.
7. The Type of Ground Truth Used:
- Engineering/Performance Data: The "ground truth" for this device's performance would be established through objective measurements and validated testing protocols for its physical properties (e.g., integrity, sterility, biocompatibility) and functional aspects (e.g., ability to reliably mix and deliver materials). This is inferred from the mentioned "Performance Data" section listing tests like Reliability, Biocompatibility, Sterilization, Shelf-life, and Simulated Use testing.
8. The Sample Size for the Training Set:
- Not Applicable. This is not a machine learning or AI device that requires a "training set."
9. How the Ground Truth for the Training Set was Established:
- Not Applicable. As this is not an AI/ML device, there is no training set or ground truth established for one.
In summary, this 510(k) document is a regulatory submission focused on demonstrating substantial equivalence to an already cleared predicate device for a physical medical instrument. It provides a list of performance tests conducted (Reliability, Biocompatibility, Sterilization, Shelf-life, Simulated Use Testing) but does not detail the specific acceptance criteria, sample sizes, or results in a quantitative manner as would be expected for a detailed study of an AI-powered diagnostic device.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows a logo for the U.S. Department of Health & Human Services. The logo consists of a circular design with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle, there is a stylized graphic of what appears to be a human figure or symbol, composed of three curved lines.
and Drug Administratio
New Hampshire Avential
ment Control Control Control - 1
Spring, MD 20993-00
April 23, 201
ONMED Corporation
Is. Dionne Sanders MS, I
egulatory Articles in Sanders MS, I
egulatory Articles in Arabican Para
1311 Concept Boulevard
argo, Florida 33773
42535 ଧ
de/Device Name: Conmed Mixing and Delivery
gulation Number: 21 CFR 880.5860
gulation Name: Piston Syring tory Class: Class rch 13, 20
March 24, Code: FM
March 13, 2
Sanders
ﺍﻟﻘﻠ ﺍﻟﻤﺮﻛﺰ ﺍﻟﻤﺪﻳﻨﺔ ﺍﻟﻤﺪﻳﻨﺔ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺎﺣﺔ ﺍﻟﻤﺴﺎﺣﺔ ﺍﻟﻤﺴﺎﻋﺪ ﺍﻟﻤﺴﺎﺣﺔ ﺍﻟﻤﺴﺘﺸﺮﻳﻦ ﺍﻟﻤﺴﺘﺸﺮﻳﻦ ﺍﻟﻤﺴﺘﺸﺮﻳﻦ ﺍﻟﻤﺴﺘﺸﺮﻳﻦ ﺍﻟﻤﺴﺘﺸﺮﻳﻦ ﺍﻟﻤﺴﺘﺸﺮﻳﻦ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴﺘﻮﻯ ﺍﻟﻤﺴ
vice is classified (see above) into either class II (Special Controls) or class III (P
subject to additional controls: Existing major regulations affective your develops, FD
se be advised that FDA's sisunos of a substantial aquivalences actemination does novers.
IDA made mindian mindia doui dovice minution desement.
In Federa segulations and mo
{1}------------------------------------------------
h in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electron
duct radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
ou letir specific advice or our labeling regulation (21 CFR Pat 801).
101 196-1 ision and Consumer Education at its foll-field mark (2).
101 196-11stor at Lesources (2000 mar
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note
the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part
807.97). For questions regarding the reporting of adverse events under the MDR regulation (21
CFR Part 803), please go to
R Part 803), please go to
p://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's
Surveillance and Biometrics/Division of Postmarket Surveillance.
may obtain other general information on your responsibilities under the Act from t
sion of Industry and Consumer Education at its toll-free number (800) 633-2041 on
7100 or a
http://www.fda.gov/ICECI/ResourcesForYou/Industry/
ComplianceEnforcement/ucm059741.htm
ncerely yours
Jennifer R. Stevenson-S
Ashar, M.D., M.B.A., F. vision of Surgical Device Evaluati
Tice of Device Evaluati
Inter for Devices and
Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K142535
Device Name CONMED Mixing and Delivery Kit
Indications for Use (Describe)
The CONMED Mixing and Delivery Kit is intended for delivery of allograft, or synthetic bone graft materials to all orthopedic surgical sites. In addition, it is designed to facilitate pre-mixing of allograft or synthetic bone graft materials with IV fluids, blood, plasma, platelet rich plasma, bone marrow or other specific blood component(s) as deemed necessary by the clinical use requirements.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the logo for Conmed Corporation. The logo consists of the word "CONMED" stacked vertically, with the letters in black. To the right of the letters is the word "CORPORATION" stacked vertically in a smaller font, with a blue line separating it from the word "CONMED". Below the text is a blue square with a white swoosh inside.
0(k) SUMMA
SUBMITTE I
CONMED Corporation
1311 Concept Blvd.
Largo, Florida 33773
none: 727-399-53
ax: 727-399-5264
Dionne Sanders MS,
April 13, 2015 ontact Person:
ate Prepared:
DEVICE II
iston Syringe
Iston Syringe (21 CFR Part 880.586 NMED Mixing and Deliver Class II
FMF Name of Device:
Common Name : Name:
Classification Name:
Regullatory Collections:
Regullatory Collass:
Product Codes:
REDICATE DEVIC III.
| Device Name: | Arthrex Mixing and Delivery System | Proposed Device | Predicate Device | |
|---|---|---|---|---|
| Company Name: | Arthrex, Inc. | CONMED Mixing and Delivery Kit | Arthrex Mixing and Delivery System(K121124) | |
| 510(k) #: | K121124 | Manufacturer | CONMED Corporation | Arthrex, Inc. |
| Intended Use | For delivery of allograft, autograft, or synthetic bone graft materials to all orthopedic surgical sites. In addition it is designed to facilitate pre-mixing of allograft, autograft or synthetic bone graft materials with IV fluids, blood, plasma, platelet rich plasma, bone marrow or other specific blood component(s) and deemed necessary by the clinical use requirements. | Same | ||
| Components | 1 each - piston syringe (3ml) w/movable plunger and cap, funnel, long luer cannula, curved luer cannula, luer cap, obturator | 1 each – piston syringe w/movable plunger and cap (3ml or 14ml), straight delivery needle, curved delivery needle, luer cap, obturator, funnel*, articulating paddle elevator**some components sold separately | ||
| TechnologicalCharacteristics | For mixing and delivery of allograft autograft and synthetic bone graft materials to all orthopedic sites. | Same | ||
| Materials | 18-month shelf life3ml syringe fill capacityCommonly used materials in the medical device industry | 5-year shelf life3ml or 14ml syringe fill capacitySame |
EVICE DESCRIPTIC IV.
The CONMED Mixing and Delivery Kit consists of a piston syringe, curved luer
camula, straight luer lock, obturator, and finnel. The kit is supplied
a single use, disposable
DICATIONS FOR US i A
INDCATIONS FOX Coaterials of Children Colleged on States Prospect of Stream
The Collection Profituals on Priliopedia australians.
Addition Microsofiale promisial, priberting
{4}------------------------------------------------
Image /page/4/Picture/0 description: The image shows the logo for ComEd Corporation. The word "COMED" is written vertically in large, bold, black letters. To the right of the word is a thin, blue line, and then the word "CORPORATION" is written vertically in smaller letters.
COMPARISION OF THE TECHNOLOGICAL CHARACTERISTICS WITH THE
PREDICATE DEVICE VI.
The CONMED Mixing and Delivery Kit is substantially equivalent in design,
manufacturing materials, intended use, principles of operation, and technical
s and the collect of safety or effectiveness.
The similarities and differences between the predicate and proposed mixing kits are:
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image shows the logo for CONMED Corporation. The text "CONMED" is stacked vertically in a bold, sans-serif font. Below the text is the word "CORPORATION" in a smaller, thinner font. Below the text is a blue square with a white, curved shape inside.
ERFORMANCE DAT VII.
Testing has been completed to demonstrate that the CONMED Mixing and Delive
Kit performs as intended and is substantially equivalent to the predicate device.
Completed testing includes the followin
- Reliability
- .
- Transportation
Biocompatibilit
Sterilization ●- .
- Shelf-life
- .
- Simulated Use Testing .
ONCLUSION VIII.
The CONNED Mixing and Delivery Kit has the interial weans trimamment
sother technal beries messes and series werivers werk met met
of the technology assessment of the comment
§ 880.5860 Piston syringe.
(a)
Identification. A piston syringe is a device intended for medical purposes that consists of a calibrated hollow barrel and a movable plunger. At one end of the barrel there is a male connector (nozzle) for fitting the female connector (hub) of a hypodermic single lumen needle. The device is used to inject fluids into, or withdraw fluids from, the body.(b)
Classification. Class II (performance standards).